| Literature DB >> 25883517 |
Benoit Banga N'Guessan1, Kassim Dosso2, Boua Narcisse Gnangoran2, Patrick Amoateng3, Isaac Julius Asiedu-Gyekye3, Angoue Paul Yapo2.
Abstract
OBJECTIVES: This study presents the antispasmodic and antibacterial properties of an ethanol extract and fractions the of stem bark of Piliostigma reticulatum.Entities:
Keywords: Antibacterial; Piliostigma reticulatum; diarrhea; spasmolytic effects
Year: 2015 PMID: 25883517 PMCID: PMC4399011 DOI: 10.4103/0975-7406.154439
Source DB: PubMed Journal: J Pharm Bioallied Sci ISSN: 0975-7406
Figure 1Dose-response effects of crude ethanolic extract (0.13-1.32 mg/mL) and its constituent fractions (0.13-0.52 mg/ml) on spontaneous contractile response of isolated rabbit duodenum preparation. Each point represents mean ± standard error of the mean (n = 6)
Inhibitory concentration (IC50) of the crude ethanolic extract of Piliostigma reticulatum and its constituent fractions on the contractile responses of isolated rabbit duodenum
Figure 2Dose-response effects of heptane fraction (0.13-0.52 mg/mL) on the spontaneous contractile response of an isolated rabbit duodenum
Figure 3Dose-response effects of dichloromethane fraction (0.13-0.52 mg/mL) on the spontaneous contractile response of an isolated rabbit duodenum
Diameters of inhibition, MIC and MBC of bacteria and gentamycin
Figure 4Effects of the dichloromethane fraction of Piliostigma reticulatum on susceptible strains of bacteria: VC - Vibrio cholerae; SD - Shigella dysenteriae; ST - Salmonella tiphymurium; SA - Staphylococcus aureus and EC - Eschérichia coli (mg/L). Data are mean ± standard error of the mean (n = 10). nsP > 0.05, ***P < 0.001 compared to gentamycin treatments (Two-way ANOVA followed by a Bonferroni's post-hoc test)
Figure 5Effects of the dichloromethane fraction of Piliostigma reticulatum on resistant strains of bacteria: VC - Vibrio cholerae; SD - Shigella dysenteriae; ST - Salmonella tiphymurium; SA - Staphylococcus aureus and EC - Eschérichia coli (mg/L). Data are mean ± standard error of the mean (n = 10). ***P < 0.001 compared to gentamycin treatments (Two-way ANOVA followed by a Bonferroni's post-hoc test)